November 25, 2013

Dr. John Rogers, MC10 Co-Founder, Featured in New Yorker Magazine.

November 21, 2013

Novocure Announces Launch of the inovitro™ Lab Research System

The inovitro laboratory research system enables scientists to study the effects of Tumor Treating Fields in cancer cells. NEW YORK, Nov. 21, 2013 /PRNewswire/ –Today, Novocure announced the launch of … Continued

November 19, 2013

Novocure Enrolls First Patients in a Randomized Trial of NovoTTF™ Therapy for Patients with Brain Metastases from Non-Small Cell Lung Cancer

HAIFA, Israel, Nov. 19, 2013 /PRNewswire/ — Novocure announced today that the first patients have enrolled in the EF-21 Study, a prospective randomized clinical study of NovoTTF™ Therapy for patients with … Continued

November 13, 2013

MC10 Named as CES Innovations 2014 Design and Engineering Award Honoree

November 12, 2013, CAMBRIDGE, MA – MC10 today announced that it has been named a 2014 International CES Innovations Design and Engineering Awards Best of Innovations Honoree along with Reebok … Continued

November 05, 2013

Novocure Announces FDA Approval of the NovoTAL™ (Transducer Array Layout) System

The NovoTAL System Enables Certified Physicians to Plan and Individualize NovoTTF™ Therapy for Recurrent Glioblastoma Patients New York, NY –November 5, 2013 –Novocure announced today that the United Statesb Food … Continued